Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients
Daniel Valle-Millares,
Óscar Brochado-Kith,
Luz Martín-Carbonero,
Lourdes Domínguez-Domínguez,
Pablo Ryan,
Ignacio De los Santos,
Sara De la Fuente,
Juan M. Castro,
María Lagarde,
Guillermo Cuevas,
Mario Mayoral-Muñoz,
Mariano Matarranz,
Victorino Díez,
Alicia Gómez-Sanz,
Paula Martínez-Román,
Celia Crespo-Bermejo,
Claudia Palladino,
María Muñoz-Muñoz,
María A. Jiménez-Sousa,
Salvador Resino,
Verónica Briz,
Amanda Fernández-Rodríguez,
on Behalf of Multidisciplinary Group of Viral Coinfection HIV/Hepatitis (COVIHEP)
Affiliations
Daniel Valle-Millares
Unit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, 28220 Majadahonda, Madrid, Spain
Óscar Brochado-Kith
Unit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, 28220 Majadahonda, Madrid, Spain
Luz Martín-Carbonero
Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain
Lourdes Domínguez-Domínguez
VIH Servicio de Medicina Interna Research Institute Hospital 12 de Octubre (i+12), 28041 Madrid, Spain
Pablo Ryan
Department of Infectious Diseases, Infanta Leonor Teaching Hospital, 28031 Madrid, Spain
Ignacio De los Santos
Internal Medicine Servicie Hospital Universitario de La Princesa, 28006 Madrid, Spain
Sara De la Fuente
Internal Medicine Service Hospital Puerta de Hierro, 28222 Madrid, Spain
Juan M. Castro
Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain
María Lagarde
VIH Servicio de Medicina Interna Research Institute Hospital 12 de Octubre (i+12), 28041 Madrid, Spain
Guillermo Cuevas
Department of Infectious Diseases, Infanta Leonor Teaching Hospital, 28031 Madrid, Spain
Mario Mayoral-Muñoz
Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain
Mariano Matarranz
VIH Servicio de Medicina Interna Research Institute Hospital 12 de Octubre (i+12), 28041 Madrid, Spain
Victorino Díez
Department of Infectious Diseases, Infanta Leonor Teaching Hospital, 28031 Madrid, Spain
Alicia Gómez-Sanz
Unit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, 28220 Majadahonda, Madrid, Spain
Paula Martínez-Román
Unit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, 28220 Majadahonda, Madrid, Spain
Celia Crespo-Bermejo
Laboratory of Reference and Research on Viral Hepatitis, National Center for Microbiology, Institute of Health Carlos III, 28220 Majadahonda, Madrid, Spain
Claudia Palladino
Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal
María Muñoz-Muñoz
Department of Animal Genetics, Instituto Nacional de Investigación y Alimentación Agraria y Alimentaria (INIA), 28040 Madrid, Spain
María A. Jiménez-Sousa
Unit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, 28220 Majadahonda, Madrid, Spain
Salvador Resino
Unit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, 28220 Majadahonda, Madrid, Spain
Verónica Briz
Laboratory of Reference and Research on Viral Hepatitis, National Center for Microbiology, Institute of Health Carlos III, 28220 Majadahonda, Madrid, Spain
Amanda Fernández-Rodríguez
Unit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, 28220 Majadahonda, Madrid, Spain
on Behalf of Multidisciplinary Group of Viral Coinfection HIV/Hepatitis (COVIHEP)
Micro RNAs (miRNAs) are essential players in HIV and HCV infections, as both viruses modulate cellular miRNAs and interact with the miRNA-mediated host response. We aim to analyze the miRNA profile of HIV patients with different exposure to HCV to explore specific signatures in the miRNA profile of PBMCs for each type of infection. We massively sequenced small RNAs of PBMCs from 117 HIV+ infected patients: 45 HIV+ patients chronically infected with HCV (HIV/HCV+), 36 HIV+ that spontaneously clarified HCV after acute infection (HIV/HCV-) and 36 HIV+ patients without previous HCV infection (HIV). Thirty-two healthy patients were used as healthy controls (HC). Differential expression analysis showed significantly differentially expressed (SDE) miRNAs in HIV/HCV+ (n = 153), HIV/HCV- (n = 169) and HIV (n = 153) patients. We found putative dysregulated pathways, such as infectious-related and PI3K signaling pathways, common in all contrasts. Specifically, putatively targeted genes involved in antifolate resistance (HIV/HV+), cancer-related pathways (HIV/HCV-) and HIF-signaling (HIV) were identified, among others. Our findings revealed that HCV strongly influences the expression profile of PBMCs from HIV patients through the disruption of its miRNome. Thus, different HCV exposure can be identified by specific miRNA signatures in PBMCs.